Trial intelligence / Profile preview

BIG 1-98: Letrozole vs Tamoxifen in Breast Cancer

NCT00004205Phase 3Completed

Sponsor
ETOP IBCSG Partners Foundation
Start
Mar 1998
Primary completion
Dec 2008
Modality
Orthosteric Ligands
Countries
3
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Mar 1998; status: completed.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00004205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call